Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PRX-03140: Completed Phase IIa enrollment

EPIX completed enrollment of 80 patients in a double-blind, placebo-controlled,

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE